CM
THC icon

CastleKnight Management’s Tenet Healthcare THC Stock Holding History

CastleKnight Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
66,100
+29,900
+83% +$5.5M 0.17% 92
2026
Q1 		$6.83M Sell
36,200
-14,600
-29% -$3.08M 0.11% 119
2025
Q4 		$10.1M Sell
50,800
-22,900
-31% -$4.63M 0.22% 58
2025
Q3 		$15M Buy
73,700
+5,800
+9% +$1.03M 0.29% 50
2025
Q2 		$12M Buy
67,900
+15,800
+30% +$2.38M 0.34% 46
2025
Q1 		$7.01M Buy
52,100
+39,300
+307% +$5.18M 0.28% 61
2024
Q4 		$1.62M Buy
12,800
+9,300
+266% +$1.38M 0.05% 192
2024
Q3 		$582K Sell
3,500
-2,600
-43% -$393K 0.02% 277
2024
Q2 		$811K Sell
6,100
-16,600
-73% -$2M 0.04% 239
2024
Q1 		$2.39M Sell
22,700
-28,100
-55% -$2.52M 0.14% 112
2023
Q4 		$3.84M Sell
50,800
-27,600
-35% -$1.75M 0.2% 56
2023
Q3 		$5.17M Buy
78,400
+2,800
+4% +$209K 0.34% 46
2023
Q2 		$6.15M Sell
75,600
-59,600
-44% -$4.24M 0.65% 26
2023
Q1 		$8.03M Buy
135,200
+32,200
+31% +$1.79M 0.83% 15
2022
Q4 		$5.03M Buy
103,000
+57,800
+128% +$2.67M 0.66% 24
2022
Q3 		$2.33M Buy
45,200
+36,200
+402% +$2.15M 0.33% 43
2022
Q2 		$473K Buy
9,000
+6,100
+210% +$425K 0.08% 155
2022
Q1 		$249K Buy
+2,900
New +$238K 0.04% 226

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

CastleKnight Management's THC Position: Q2 2026 in Review

CastleKnight Management increased its Tenet Healthcare (THC) stake by 83% in Q2 2026, buying an estimated $5.5M and bringing the position to 66,100 shares worth $12.4M. The position accounts for 0.17% of the portfolio, ranked #92.

CastleKnight Management first reported a position in THC in Q1 2022 and has held it in 18 quarters since. The position peaked at $15M in Q3 2025. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • CastleKnight Management held 66,100 shares of Tenet Healthcare worth $12.4M as of Q2 2026.
  • CastleKnight Management bought 29,900 Tenet Healthcare shares in Q2 2026, an estimated $5.5M.
  • Tenet Healthcare made up 0.17% of CastleKnight Management's portfolio in Q2 2026, its #92 holding.
  • CastleKnight Management first reported a position in Tenet Healthcare in Q1 2022 and has held it in 18 quarters since.
  • CastleKnight Management's Tenet Healthcare position peaked at $15M in Q3 2025.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on CastleKnight Management's 13F filing for Q2 2026, filed 14 Aug 2026.